Lynx Investment Advisory Pfizer Inc Transaction History
Lynx Investment Advisory
- $147 Billion
- Q4 2024
A detailed history of Lynx Investment Advisory transactions in Pfizer Inc stock. As of the latest transaction made, Lynx Investment Advisory holds 31,161 shares of PFE stock, worth $823,585. This represents 0.56% of its overall portfolio holdings.
Number of Shares
31,161
Previous 27,295
14.16%
Holding current value
$823,585
Previous $790 Million
4.66%
% of portfolio
0.56%
Previous 0.57%
Shares
3 transactions
Others Institutions Holding PFE
# of Institutions
3,367Shares Held
3.69BCall Options Held
106MPut Options Held
123M-
Vanguard Group Inc Valley Forge, PA519MShares$13.7 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$11.2 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.68 Billion0.31% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA155MShares$4.11 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA140MShares$3.7 Billion0.7% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $148B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...